Bionaut key facts
- Developer of microscale robotic devices designed for targeted therapeutic delivery to specific areas affected by severe brain disorders.
- Bionaut’s last known valuation is $123.3M.
- It has raised $83.0M; the latest was Later Stage VC ($12.9M) in May 2024.
- Notable investors include Alumni Ventures, Khosla Ventures, Gaingels, Calm Ventures, OurCrowd — 29 tracked in total.
- Status: Privately Held (backing).
Who backs Bionaut
29+Membership and data by Private Market View
- ·The complete investor list: 29 names
- ·Watch Bionaut: the Monday email on marks, rounds and moves
Bionaut funding rounds
No funding rounds for Bionaut are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bionaut valuation
Bionaut's last known valuation is $123 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Bionaut investors
29 investors are on record for Bionaut, including Alumni Ventures, Khosla Ventures, Gaingels and Calm Ventures. By type, the record holds 12 venture capital firms and 1 family office.
About Bionaut
Developer of microscale robotic devices designed for targeted therapeutic delivery to specific areas affected by severe brain disorders. The company utilizes precision micro-technology to transport biologics or small-molecule therapies directly to localized disease sites, enabling medical professionals to achieve minimally invasive treatments, improve targeting accuracy, and potentially reduce side effects for patients requiring advanced neurological interventions.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2016
- Employees
- 41
- Website
- bionautlabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Bionaut’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.